Logo
N

N-Power Medicine, Inc.

87 employees

N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors. The N-Power Platform consists of: - The real-time Kaleido™ Registry, conducted with patient consent, that defines standardized data collection at the point of care and is malleable to partner needs, - A technology solution that enables data collection and analysis, and - Embedded on-site and virtual staff who support delivery of routine care, implement standardized, registry protocol-defined data collection and augment site staff in clinical research. By partnering with oncologists, research staff and patients in unlocking the full potential of every patient’s data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development.

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2021

Funding rounds raised

N

N-Power Medicine, Inc. raised undisclosed on June 21, 2024

Investors: Merck Global Health Innovation Fund

FAQ